After decades of false starts, new immunotherapies are achieving long-lasting remissions in patients with extremely deadly cancers. Some doctors are even daring to use the word “cure.”
After decades of false starts, new immunotherapies are achieving long-lasting remissions in patients with extremely deadly cancers. Some doctors are even daring to use the word “cure.”